ERAGEN

USPTO USPTO 2004 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke ERAGEN wurde als Wortmarke am 23.06.2004 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 19.07.2005 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails

Markenform Wortmarke
Aktenzeichen 78440373
Registernummer 2970737
Anmeldedatum 23. Juni 2004
Veröffentlichungsdatum 26. April 2005
Eintragungsdatum 19. Juli 2005

Markeninhaber

918 Deming Way
537171933 Madison
US

Markenvertreter

Waren und Dienstleistungen

1 Reagents and diagnostic preparations for scientific or research use
9 [ Computer hardware and software for use in bioinformatic analysis, namely, performing phylogenetic analysis, predicting protein structure-function, storing, retrieving, analyzing, and graphically representing biological data containing genomic, proteomic, and nucleic acid sequence data and manuals sold therewith; a biological database recorded on computer media containing biological data for use with the aforementioned software; ] computer software for performing analysis of experimental data obtained by the Polymerase Chain Reaction (PCR) and related applications and manuals sold therewith; graphical user interface software for navigating a biological database and performing analysis of experimental data obtained by the Polymerase Chain Reaction (PCR) and related applications
42 [ Scientific research and technical consulting services and research relating thereto in the fields of bioinformatics, nucleic acid diagnostics, and drug discovery; database design and development services, namely, biological databases for the identification and analysis of genes and proteins; design and development of computer software and data, namely, computer software and data for biological analysis; computer support services, namely, technical support and software and data update services; design and development of proprietary bioinformatics technology platforms, namely, proprietary bioinformatics technology platforms for target identification and validation, protein structure and function predictions, and biological model selection and interpretation; laboratory research, design and development for new products for others in the fields of bioinformatics, nucleic acid diagnostics, and drug discovery ]
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378440373